Cuestiones profesionales en la psicofarmacoterapia para psicólogos


  • Robert E. McGrath Fairleigh Dickinson University
  • Morgan T. Sammons US.Navy Bureau of Medicine and Surgery
  • Anita Brown Hampton University
  • Jack G. Wiggins Missouri Institute of Mental Health
  • Ronald F. Levant Nova Southeastern University
  • Wendy Stock Alliant International University


Palabras clave:

psicoterapia, identidad profesional del psicólogo, psicofarmacología, autorización para prescribir


La mayor parte de la discusión crítica sobre la autoridad prescriptiva de los psicólogos se ha centrado en la cuestión de si esta es la dirección acertada para la profesión. Los autores sostienen que el discurso sobre la autoridad prescriptiva debería progresar hacia la identificación de los retos que esperan a la psicología como profesión prescriptiva, con la meta de anticipar y redirigir aquellos retos tan pronto como sea posible dentro del proceso. Los autores identifican un número de estos retos potenciales, incluyendo cuestiones tanto generales como de identidad profesional como cuestiones más prácticas. En algunos casos, los autores expresan sus opiniones sobre estos temas, pero su intención es la de estimular una discusión razonada sobre las cuestiones con las que los psicólogos deberán afrontarse.


Los datos de descargas todavía no están disponibles.


American Psychological Association. (1996) Recommended postdoctoral training in psychopharmacology for prescription privileges. Washington Dc: Autor.

Bartels, S. J., Dums, A.R., Oxmann, T.E., Shneider, L.S., Areaan, P.A., Alexopulos, G.S., & Jeste, D.V. (2002) Evidence based practices in geriatric mental health care: Psychiatric service, 53, 1419-1431.

Bodenheimer, T. (2000) Uneasy aliance-clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539-1544.

Bray, J.H., Enright; M.F., & Rogers, J. (1997) Collaboration with primary care physicians. In J. A. Morris (Ed), Practicing Psychology in rural settings: Hospital privileges and collaborative care (pp.55-65): Washington, DC: American Psychology Association.

Casacalenda, N., Perry, J.C., & Looper, K. (2002) Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions. American Journal of Psychiatry, 159, 1354-1360.

Cho, M., Shohara, R., Schissel, A., & Rennie, D. (2000) Policies on faculty conflicts of interest at US universities. Journal of American Association, 284,2203-2208.

Choludry, N., K., Stelfox, H.T., Detsky, A.S. (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Journal of American Medical Association, 287, 1232-1234

Davidoff, F., De Angelis, C.D., Drazen, J.M., Hoey, J., Hojgard, L., Horton R., et al. (2001) Sponsorship, authorship, and accountability. Journal of American Medical Association 287,612-617.

De Nelsky, G., L. (1996) The case against prescriptions privileges for psychologists, American Psychologist, 51, 207-211.

Engel, G. L. (1977, April 8) The need for a new medical model: A challenge for biomedicine. Science, 196,129-136., 158, 1956-1963.

Gabbard, G., O., Kay, J. (2001). The fate of integrated treatment: Whatever happened to the biopsychosocial psychiatrist? American Journal of Psychiatry.

Goldman, W., Mcculloch, J., Cuffel, B., Zarin, D., Suarez, A& Burns, B., J. (1998). Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression: Psychiatric Services, 49, 477-482.

Hayes, S., & Heiby, E. (1996). Psychology’s drug problem: Do we need a fix or should we just say no. American Psychologist, 51, 198-206.

Heibi, E.M. (2002) Concluding remarks on the debate about prescription privileges for psychologists. Journal of Clinical Psychology, 58, 709-722.

Hines, D. (1997) Arguments of prescription privileges for psychologists. American Psychologist, 52, 270-271.

Khan, A., Leventhal, R., M. & Khan, S.R. (2002) Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. Journal of Clinic Psychopharmacology, 22, 40-45.

Kirsch, I., Moore, T., J., Scoboria, A., & Nicolls, S.S. (2002, July 15) The emperor’s new drugs: An analysis antidepressant medication data submitted to the U.S. Food and drug administration (Article 23). Prevention and treatment, 5. Retrieved September 25, 2002, from htttp:// volume5/ Pre0050023a.html.

Lawton-Smuth, S. (2002). Patient adherence with antidepressant treatment. British Journal of Psychiatry, 181,78

Levant, R. F., Sammons, M., T. (2002): Of Cassandras, canards, and the dog in the night- time. Journal of Clinical Psychology, 9, 259-263.

Luhrmann, T., M. (2000) Of two minds. The growing disorder in American psychiatry. New York: Knopf.

Mojtabai, R., Lavelle, J., Gibson, P., J., Sholer, N.L, Craig, T.J., Carlson, G.A., & Bromet, E.J. (2002) Gaps in use antipsychotics after discharge by first- admission patients with schizophrenia, 1989 to 1996. Psychiatric Services, 53, 337-339.

Moncrieff, L. (20001) Are antidepressants overrated? A review of methodological problems in antidepressants trials. Journal of Nervous and Mental Disease, 189, 288-295.

National Depressive And Manic Depressive Association (2000) Beyond diagnosis: depression and treatment- A call to action to the primary care community and peopl with depression. Chicago: Author.

Norfleet, M. A. (2002). Responding to society’s needs: Prescription privileges for psychologists. Journal of Clinical Psychology, 58, 599–610.

Pampallona, S., Bollini, P., & Tibaldi, G. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104–109.

Pincus, H. A., Zarin, D. A., Tanielian, T. L., Johnson, J. L., West, J. C., Pettit, A. R., et al. (1999). Psychiatric patients and treatments in 1997: Findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry, 56, 441–449.

Robiner, W. N., Bearman, D. L., Berman, M., Grove, W. M., Colon, E., Armstrong, J., & Mareck, S. (2002). Prescriptive authority for psychologists: A looming health hazard? Clinical Psychology: Science and Practice, 9, 231–248.

Ross, J. S., Lurie, P., & Wolfe, S. M. (2000, July 19). Medical education services suppliers: A threat to physician education. Retrieved July 24, 2002, from

Sammons, M. T. (2001). Combined treatments for mental disorders: Clinical dilemmas. In M. T. Sammons & N. B. Schmidt (Eds.), Combined treatments for mental disorders: A guide to psychological and pharmacological interventions (pp. 11–32). Washington, DC: American Psychological Association.

Satcher, D. (1999). Mental health: A report of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services.

Shakow, D. (1965). Seventeen years later: Clinical psychology in the light of the 1947 Committee on Training in Clinical Psychology report. American Psychologist, 20, 353–362.

Sward, K. (1950). Are the psychologists afraid of therapy? American Psychologist, 5, 50–54.




Cómo citar

McGrath, R. E., Sammons, M. T., Brown, A., Wiggins, J. G., Levant, R. F., & Stock, W. (2007). Cuestiones profesionales en la psicofarmacoterapia para psicólogos. Revista de Psicoterapia, 18(69), 11–25.



Artículo de monográfico